Osteoporosis Canada


Dr Jonathan Adachi

Dr. Jonathan Adachi

McMaster University | Hamilton, ON

Dr. Jonathan Adachi is a Professor of Medicine at the Michael G. DeGroote School of Medicine, McMaster University. He is the Actavis Chair for Better Bone Health in Rheumatology. Dr. Adachi has been involved in clinical trials and epidemiologic research. He either holds or is a co-investigator in several CIHR funded studies including the 20 year Canadian Multicentre Osteoporosis Study (CaMOS), and a separate study examining pQCT, HRpQCT and pMRI images of bone structure and strength to determine the relationship of bone structure and muscle to fractures in a subset of CaMOS subjects.

Dr Adachi has over 590 peer reviewed publications and is a respected leader in bone research in Canada and Internationally. He was awarded the Lindy Fraser Award by Osteoporosis Canada. In 2006, he received the North American Menopause Society award for Innovation in Osteoporosis Research. In 2012, he received the Queen Elizabeth II Diamond Jubilee Medal for his work in osteoporosis and in 2014 he was received the Olof Johnell Science Award that honours an individual who has contributed to the field of osteoporosis in a scientific or policy implementation area worldwide. In 2019 he was awarded the Herbert Fleisch Medal by ESCEO-IOF in recognition of his outstanding and innovative contributions in basic or translational science.

Dr Angela M Cheung

Dr. Angela M. Cheung

University of Toronto / University Health Network | Toronto, ON

Dr. Angela M. Cheung is Professor of Medicine, KY and Betty Ho Chair in Integrative Medicine at University of Toronto (UT) and Senior Scientist at University Health Network (UHN). She is currently holding a Tier 1 Canada Research Chair in Musculoskeletal and Postmenopausal Health, and has held a Canadian Institutes of Health Research (CIHR) Senior Investigator award, the Canadian Society of Internal Medicine (CSIM) David Sackett Senior Investigator award, the Ontario Premier Research Award and the University of Toronto Eudenie Stuart Mentorship award. She is a member of the Endocrine Society Clinical Guidelines Committee, chair of the International Society of Clinical Densitometry Canadian Panel, and the past chair of Osteoporosis Canada Scientific Advisory Council. She obtained her M.D. degree from Johns Hopkins University School of Medicine in 1988, and her PhD degree from Harvard University in 1997. She is a Fellow of the Royal College of Physicians of Canada and has been in clinical practice for >30 years. Twitter @AngelaMCheung

Dr. Steven Cummings

Dr. Steve Cummings

UC San Francisco | San Francisco, CA, USA

Dr. Cummings is an Internal Medicine specialist and Professor of Medicine, Epidemiology, and Biostatistics at UC San Francisco. He is the Executive Director of the San Francisco Coordinating Center in the California Pacific Medical Center Research Institute. He is an internationally recognized expert on osteoporosis and prevention of fractures. He has led the large clinical trials that won FDA approval for most of the drug treatments for osteoporosis – Alendronate, Zoledronate, Denosumab, and Raloxifene. He has designed and led large longitudinal studies about risk factors for osteoporosis, including the Study of Osteoporotic Fractures for older women and MrOS for older men. He has published articles about the risk of fractures in patients with medical and neurolgic conditions, He has over 600 peer-reviewed publications and won several awards for his research in osteoporosis including ASBMR’s William Neuman Award for Outstanding and Major Scientific Contributions and Frederick Bartter Award for Excellence in Clinical Research in Bone and Mineral Research. He has also been elected to the prestigious National Academy of Medicine in the National Academy of Sciences for his contributions to Clinical Research. 

Dr. Claudia Gagnon

Dr. Claudia Gagnon

Université Laval | MONTREAL, QC
Dr. Claudia Gagnon is an Associate Professor in the Department of Medicine at Université Laval and a clinician-researcher scholar of the Fonds de recherche en santé du Québec. She devotes 50% of her time as a researcher at CHU de Québec Research Centre and at Québec Heart and Lung Institute Research Centre in Québec City. She also practices as an adult endocrinologist at CHU de Québec. After completing residency training in adult endocrinology at Université de Sherbrooke in 2006, she undertook a 3-year fellowship in metabolic bone diseases and phosphocalcic metabolism in Melbourne, Australia, under the supervision of Prof. Peter Ebeling and Prof. Robin Daly. Her research focuses on the impact of obesity, diabetes and their treatments (in particular bariatric surgery) on bone health. She received funding from Diabetes Canada, Diabète Québec and the Canadian Institutes of Health Research and published over 50 articles in peer-reviewed journals. She has been awarded the 2019 Jean-Davignon young investigator award from the Cardiometabolic, diabetes and obesity FRQ-S network, the 2017 research prize of the Fédération des médecins spécialistes du Québec and a New Investigator Award at the International Symposium on the Nutritional Aspects of Osteoporosis in 2015. She is involved in various committees including Diabète Québec, Diabetes Canada and the Scientific Advisory Council of Osteoporosis Canada.

Dr Famida Jiwa

Dr. Famida Jiwa

Dr. Jiwa is the President and CEO of Osteoporosis Canada, and has been with the organization since 2006. Prior to joining Osteoporosis Canada, Dr. Jiwa was the former Provincial Osteoporosis Co-ordinator, employed by the Ontario Ministry of Health and Long Term Care and charged with rolling out all aspects of the $5 million annual Ontario Osteoporosis Strategy. Prior to this and after leaving her private practice in Orlando, Florida, Dr. Jiwa was a Program Consultant for the Acute Services Division of the Ministry of Health, where she played a significant role in project planning, implementation and evaluation of a number of provincial health initiatives, including chronic kidney disease, asthma and age-related macular degeneration. In 2020 Dr. Jiwa was elected to the Board of Directors of the International Osteoporosis Foundation, representing North America, for a term of 4 years. She also serves as the chair of the Patient Societies Subcommittee of the Committee of National Societies (CNS) of the International Osteoporosis Foundation (IOF). In 2020, Dr. Jiwa was awarded the CNS Medal from the International Osteoporosis Foundation. In 2016, she was awarded the President’s Award from the International Osteoporosis Foundation. She is also the recipient of the Queen Elizabeth II Diamond Jubilee Medal. Dr. Jiwa has also attained the designation of Certified Health Executive from the Canadian College of Health Service Executives, and in 2017 she completed the Strategic Perspectives in Nonprofit Management program at Harvard Business School. She holds a Masters Degree in Health Administration from the Department of Health Policy, Management and Evaluation from the University of Toronto, a Doctorate of Chiropractic from the Canadian Memorial Chiropractic College in Toronto, as well as an Honours Bachelor of Science, Genetics and Psychology from the University of Toronto.

Dr. R.G. Josse

Dr. R.G. Josse

Dr. R. Josse graduated in Medicine with Honours from the University of London . He undertook Postgraduate Training at various Teaching Hospitals at the University of London and then came to Canada and completed his Endocrine Clinical Training, after which he did a Research Fellowship at the University of Toronto followed by a further Clinical Fellowship at the Massachusetts General Hospital in Boston. He holds Fellowships in Internal Medicine from the American College of Physicians, Royal College of Physicians of London and Internal Medicine and Endocrinology Fellowships from the Royal College of Physicians of Canada. He is also a fellow of the American College of Endocrinology He is a Full Professor in the Departments of Medicine and Nutritional Sciences at the University of Toronto. He is also an adjunct scientist in the Li Ka Shing knowledge translation institute at St Michael’s Hospital ( SMH). He is the past head of the Division of Endocrinology and Metabolism and completed a term as Associate Physician-in-Chief at SMH. He is the director of the Metabolic Bone Disease and Osteoporosis Centre at SMH.He is an associate staff physician at UHN( Toronto General hospital) in the division of endocrinology and metabolism.He was the Toronto Director of the Canadian Multicentre Osteoporosis Study( CaMos). He is a consultant to ( and a past Chair of ) the Scientific Advisory Council of the Osteoporosis Society of Canada ( now Osteoporosis Canada) .He is a member of the committee of scientific advisors of the International Osteoporosis Foundation( IOF ). He is a past President of the Canadian Society of Endocrinology and Metabolism (CSEM) and was the inaugural chair of the CHE development and e-CME committee of the CSEM. He received the 2007 Distinguished Service Award of the CSEM..He has also received the 2007 Distinction in Clinical Endocrinology award of the American College of Endocrinology. He is a past recipient of the Lindsay Fraser award of Osteoporosis Canada.He received the 2012 Queen Elizabeth 11 Diamond Jubilee award medal . In 2015 he received the clinician educator award of CSEM His major research interests include calcium metabolism and osteoporosis as well as diabetes, and various nutritional metabolic problems. He has published/co-authored over three hundred and twenty articles in peer reviewed journals and twenty-one book chapters. He lectures widely both nationally and internationally on various endocrine and metabolic topics.

Dr. David Kendler

Dr. David Kendler

Prohealth Clinical Research | VANCOUVER, BC
Dr. Kendler graduated from the MD program at the University of Toronto in 1977. After completing a rotating internship in Toronto, he practiced for several years in Canada, Botswana, and New Zealand. He returned to Internal Medicine training in 1983 in Christchurch, New Zealand and in 1984 joined the Internal Medicine program in Halifax, Canada. In 1985 he moved to Vancouver to complete Internal Medicine and Endocrinology training at the University of British Columbia. After a 2-year thyroid immunology Fellowship in New York, he returned to the University of British Columbia Faculty of Medicine where he is now a Professor of Medicine in Endocrinology. He has led osteoporosis programs at Children and Women’s Hospital and St. Paul’s Hospital. He is the director of Prohealth Clinical Research, a major North American centre for clinical trials in the area of osteoporosis. He serves on the Scientific Advisory Council of Osteoporosis Canada and Chairs the Western Osteoporosis Alliance. He is a Past-President of the International Society for Clinical Densitometry. He is a member of the Committee of Scientific Advisors of the International Osteoporosis Foundation and is co-Chair of the Western Osteoporosis Alliance. He has been awarded the John Bilezekian ISCD Global Leadership Award and the IOF President’s award. He has served on the Board of Directors of the Canadian Menopause Society. He has published over 140 peer-reviewed papers on osteoporosis therapies, osteoporosis risk assessment and autoimmune thyroid disease.

Dr. Aliya Khan

Dr. Aliya Khan


Aliya Khan is a Professor of Clinical Medicine at McMaster University, Director of the Calcium Disorders Clinic and the Fellowship in Metabolic Bone Disease at McMaster University.  She graduated from the University of Ottawa Medical School with honors and completed postgraduate training at the University of Toronto.  She has published over 200 scientific papers and numerous chapters and books on osteoporosis and parathyroid disease. She has received numerous national and international awards including the Queen’s Diamond Jubilee Medal for excellence, International Hypoparathyroidism Award, International Osteoporosis Foundation award for publishing excellence and recognized by Osteoporosis Canada for outstanding contributions to research and education.  She was recognized as being in the top 0.1% of the world experts in hyperparathyroidism by Expertscape. 

Sandra Kim

Dr. Sandra Kim

Women’s College Hospital / University of Toronto | TORONTO, ON
Sandra Kim is the past chair of the Scientific Advisory Council for Osteoporosis Canada, and is co-chair of the Pharmacotherapy working group for the OC Clinical Practice Guidelines Update. She is the director of the Centre for Osteoporosis & Bone Health at Women’s College Hospital and Assistant Professor of Medicine at the University of Toronto in the Division of Endocrinology & Metabolism. She is involved with the Ontario Osteoporosis Strategy in leading osteoporosis care outreach to underserviced communities through telemedicine and is a member of the Canadian panel for the International Society for Clinical Densitometry. Dr. Kim is actively involved in teaching at the undergraduate and postgraduate levels and is the recipient of several education awards. Her research interests include evaluating outcomes of osteoporosis care delivered by telemedicine, quality of bone density reports and transgender bone health.

Dr Suzanne Morin

Dr. Suzanne Morin

McGill University | MONTREAL, QC
Dr Morin graduated from the Faculty of Medicine at Université Laval de Québec, did her Internal Medicine specialty training and obtained a Master’s in epidemiology and biostatistics from McGill University, where she is now Associate Professor in the Department of Medicine, Director of the Division of General Internal Medicine at the McGill University Health Centre, and scientist at the Centre for Outcomes Research and Evaluation of the Research Institute of the McGill University Health Centre. Dr Morin’s research program includes evaluation of outcomes of osteoporosis and fractures and of initiatives to improve fracture risk, pain management and functional recovery post- fracture with an interest in using wearables and mobile applications. She is a leader in clinical practice guidelines development for the management and prevention of osteoporosis and fractures. She is a scholar from the Fonds de Recherche du Québec en Santé, and has received funding from the Canadian Institutes of Health Research and other peer-reviewed agencies. She is a member of Advisory Board of the Institute of Musculoskeletal Health and Arthritis (CIHR), is past-Chair of the Scientific Advisory Council of Osteoporosis Canada and a member of the Council of Scientific Advisors of the International Osteoporosis Foundation.

Dr. Alexandra Papaioannou

Dr. Alexandra Papaioannou

McMaster University | Hamilton, ON
Dr. Alexandra Papaioannou is a Professor in the Department of Medicine and a Geriatrician at Hamilton Health Sciences. She is Executive Director of the GERAS Centre for Aging Research at Hamilton Health Sciences and RGP (c) Chair. She holds an Eli Lilly Research Chair at McMaster University. She has a joint appointment in the Division of Rheumatology, and is past Director, Division of Geriatric Medicine, McMaster. Dr Papaioannou is an Associate Member in the Department of Health Research Methods, Evidence and Impact, and a faculty member in the Medical Sciences, Physiology & Pharmacology Graduate Studies Program. Dr. Papaioannou is ranked in the top 5% of faculty in the Department Medicine at McMaster University for research productivity and mentorship with 350+ peer-reviewed publications, 16 book chapters and 425 published abstracts (h-index 61; 15818+ citations). She is a member of the McMaster Institute for Research on Aging (MIRA). She is past chair of the Scientific Advisory Council of Osteoporosis Canada (OC) and past Chair of the Board. She is a member of the Scientific Advisors of Osteoporosis Canada, and the International Osteoporosis Foundation. Dr. Papaioannou was lead author on the Osteoporosis Canada Guidelines, published in Canadian Medical Association Journal (CMAJ) October 2010 and 2015. She is the project lead for the Ontario Osteoporosis Strategy for Fracture Prevention in Long-term Care, and lead for the Frailty Interest Group for the Canadian Geriatrics Society. Dr. Papaioannou has received a number of awards including the Ronald Cape Distinguished Service Award, to recognize an individual who has made an outstanding contribution to the health care of older adults in Canada, the Ontario Career Scientist Award, the Service Award for Geriatric Excellence (SAGE), Category: Executive/Senior Leadership, awarded by the Regional Geriatric Program central (RGPc), the McMaster Department of Medicine Teaching Award for Postgraduate Teaching, the Ontario College of Family Physicians Certificate of Recognition for her contributions to primary care, the YWCA Hamilton Women of Distinction Award – Health & Wellness, and the Lindy Fraser Award from Osteoporosis Canada.

Rowena Ridout

Dr. Rowena Ridout

Toronto Western Hospital / University Health Network | Toronto, ON
Dr. Ridout is an endocrinologist at the Toronto Western Hospital, University Health Network and a staff physician at the UHN/MSH Osteoporosis Program. She completed her undergraduate and postgraduate medical training at the University of Toronto. She has been involved in clinical research in osteoporosis including the attainment and maintenance of peak bone mass, the treatment of steroid-induced osteoporosis in boys with Duchene Muscular Dystrophy and interventions in the fracture clinic. She is an Assistant Professor of Medicine at the University of Toronto, and her primary academic activity is teaching and education.
© Osteoporosis Canada, 2022
Charitable Registration No. 89551 0931 RR 0001